Dosidal · Poland
Ifirmasta
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:presentation:89293 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | rpl-pack-id: 89293 eu-number: EU/1/08/480/016 |
| Source authority | URPL |
| Read date | 2026-11-15T02:02:49Z |
| controlled status | availability_category: Rp definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf narcotic_or_psychotropic: False state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: C09CA04 deleted: False eu_pack_number: EU/1/08/480/016 form: Tabletki powlekane holder: Krka, d.d., Novo mesto medicine: Ifirmasta pack_units: informacjeDodatkowe: w blistrze perforowanym jednostkaPojemnosci: tabl. pojemnosc: 56 procedure: CEN routes: doustna strength: 300 mg substances: amount: 300 substance: Irbesartanum unit: mg state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| pack product code | state: unknown |
| prescription class | availability_category: Rp definitions: https://eli.gov.pl/eli/DU/2016/1769/ogl/pol/pdf prescription: True state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53JcUyX05OMKUsu2XGgkAFHoKzMjbXpb9WVSAMm3dQk6qf4pUOl19ynfssSGrfNNJ3oom7yMpIz0UV4J4OG5cI8QVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |